Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART

• Authors: Kelsie Brooks, Emory University; Harrison F Omondi, Simon Fraser University; Richard H Liang, British Columbia Ctr Excellence HIV AIDS; Hanwei Sudderuddin, British Columbia Ctr Excellence HIV AIDS; Bradley R Jones, British Columbia Ctr Excellence HIV AIDS; Jeffrey B Joy, British Columbia Ctr Excellence HIV AIDS; Chanson J Brumme, British Columbia Ctr Excellence HIV AIDS; Eric Hunter, Emory University; Zabrina L Brumme, Simon Fraser University
• Journal Title: FRONTIERS IN MICROBIOLOGY
• Volume: Volume 12
• Publisher: FRONTIERS MEDIA SA | 2021-08-19, Pages 719153-719153
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.3389/fmicb.2021.719153
• Subjects: Health Sciences, Medicine and Surgery; Health Sciences, Pathology
• Keywords: Science & Technology; Life Sciences & Biomedicine; Microbiology; HIV; persistence; reservoir; within-host phylogenetic analysis; proviral half-life; LATENT RESERVOIR; AFRICA

Abstract

Human immunodeficiency virus (HIV) can persist as an integrated provirus, in a transcriptionally repressed state, within infected cells. This small yet enduring pool of cellular reservoirs that harbor replication-competent HIV is the main barrier to cure. Entry of viral sequences into cellular reservoirs begins shortly after infection, and cells containing integrated proviral DNA are extremely stable once suppressive antiretroviral therapy (ART) is initiated. During untreated HIV infection however, reservoir turnover is likely to be more dynamic. Understanding these dynamics is important because the longevity of the persisting proviral pool during untreated infection dictates reservoir composition at ART initiation. If the persisting proviral pool turns over slowly pre-ART, then HIV sequences seeded into it during early infection would have a high likelihood of persisting for long periods. However, if pre-ART turnover was rapid, the persisting proviral pool would rapidly shift toward recently circulating HIV sequences. One-way to estimate this turnover rate is from the age distributions of proviruses sampled shortly after therapy initiation: this is because, at the time of sampling, the majority of proviral turnover would have already occurred prior to ART. Recently, methods to estimate a provirus’ age from its sequence have made this possible. Using data from 12 individuals with HIV subtype C for whom proviral ages had been determined phylogenetically, we estimated that the average proviral half-life during untreated infection was 0.78 (range 0.45–2.38) years, which is >15 times faster than that of proviral DNA during suppressive ART. We further show that proviral turnover during untreated infection correlates with both viral setpoint and rate of CD4+ T-cell decline during this period. Overall, our results support dynamic proviral turnover pre-ART in most individuals, which helps explain why many individuals’ reservoirs are skewed toward younger HIV sequences. Broadly, our findings are consistent with the notion that active viral replication creates an environment less favorable to proviral persistence, while viral suppression creates conditions more favorable to persistence, where ART stabilizes the proviral pool by dramatically slowing its rate of decay. Strategies to inhibit this stabilizing effect and/or to enhance reservoir turnover during ART could represent additional strategies to reduce the HIV reservoir.